106 related articles for article (PubMed ID: 1886348)
1. [Effect of betaxolol and timolol on visual fields in glaucoma patients].
Messmer C; Stümpfig D; Flammer J
Klin Monbl Augenheilkd; 1991 May; 198(5):330-1. PubMed ID: 1886348
[TBL] [Abstract][Full Text] [Related]
2. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
3. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
Miki H; Miki K
J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
[TBL] [Abstract][Full Text] [Related]
4. Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients.
Araie M; Azuma I; Kitazawa Y
Jpn J Ophthalmol; 2003; 47(2):199-207. PubMed ID: 12738555
[TBL] [Abstract][Full Text] [Related]
5. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
6. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
Vainio-Jylhä E; Vuori ML
Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
[TBL] [Abstract][Full Text] [Related]
7. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.
Collignon-Brach J
Surv Ophthalmol; 1994 May; 38 Suppl():S149-55. PubMed ID: 7940136
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
Dobre X
Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
[TBL] [Abstract][Full Text] [Related]
9. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
Messmer C; Flammer J; Stümpfig D
Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma.
Collignon-Brach J
Curr Eye Res; 1992 Jan; 11(1):1-3. PubMed ID: 1559386
[TBL] [Abstract][Full Text] [Related]
11. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
[TBL] [Abstract][Full Text] [Related]
12. Longterm visual field follow-up of glaucoma patients treated with beta-blockers.
Kaiser HJ; Flammer J; Stümpfig D; Hendrickson P
Surv Ophthalmol; 1994 May; 38 Suppl():S156-9; discussion S160. PubMed ID: 7940137
[TBL] [Abstract][Full Text] [Related]
13. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
14. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
15. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
17. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
18. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
